MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cdt3.11

Медицинская библиотека · Chronic diseases and translational medicine · 2022

Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review.

Prabhu Srinivasan, Vijayakumar Subramaniyan, Praseetha Pabakaran

СтатьяОбзорПеревод в очереди

Аннотация

Most of the medical and nonmedical research labs, all around the world, are racing against time to produce an effective vaccine or an antiviral medicine for coronavirus disease 2019 (COVID-19). Conventional medicines and novel nano-materials including chemical and herbal-based compounds are all into positive trials toward coronaviruses and other pandemic infections. Among them, natural immune boosters have attracted physicians because of their longevity and reliability for fewer side effects. This is a review article with a detailed picture of an unexplored antiviral source with maximum potency in curing viral infections. Cyanobacteriae have been known for centuries and are rich in secondary metabolites of proteins, biopeptides, and polysaccharides for prominent antiviral action against chest infections. But detailed exploratory research is required to purify, scale-up, and commercialize the pharmacologically active agents from these drug reserves.

Для цитирования: Prabhu Srinivasan, Vijayakumar Subramaniyan, Praseetha Pabakaran. Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review.. Chronic diseases and translational medicine. 2022. DOI: 10.1002/cdt3.11.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.